1-[2-(dimethylamino)ethyl]pyrazole-3-sulfonamide;1-[1-[2-(dimethylamino)ethyl]pyrazol-3-yl]sulfonyl-3-[5-(2-methoxy-4-pyridinyl)-2,3-dihydro-1H-inden-4-yl]urea;5-(2-methoxy-4-pyridinyl)-2,3-dihydro-1H-inden-4-amine
C45H58N12O7S2 — CID 159954762
Data last refreshed: (MolForge compound catalog, from PubChem)
About 1-[2-(dimethylamino)ethyl]pyrazole-3-sulfonamide;1-[1-[2-(dimethylamino)ethyl]pyrazol-3-yl]sulfonyl-3-[5-(2-methoxy-4-pyridinyl)-2,3-dihydro-1H-inden-4-yl]urea;5-(2-methoxy-4-pyridinyl)-2,3-dihydro-1H-inden-4-amine
1-[2-(dimethylamino)ethyl]pyrazole-3-sulfonamide;1-[1-[2-(dimethylamino)ethyl]pyrazol-3-yl]sulfonyl-3-[5-(2-methoxy-4-pyridinyl)-2,3-dihydro-1H-inden-4-yl]urea;5-(2-methoxy-4-pyridinyl)-2,3-dihydro-1H-inden-4-amine (PubChem CID 159954762) has the molecular formula C45H58N12O7S2 and a molecular weight of 943.17 g/mol. Its IUPAC name is 1-[2-(dimethylamino)ethyl]pyrazole-3-sulfonamide;1-[1-[2-(dimethylamino)ethyl]pyrazol-3-yl]sulfonyl-3-[5-(2-methoxy-4-pyridinyl)-2,3-dihydro-1H-inden-4-yl]urea;5-(2-methoxy-4-pyridinyl)-2,3-dihydro-1H-inden-4-amine.
Molecular Properties
| Compound Name | 1-[2-(dimethylamino)ethyl]pyrazole-3-sulfonamide;1-[1-[2-(dimethylamino)ethyl]pyrazol-3-yl]sulfonyl-3-[5-(2-methoxy-4-pyridinyl)-2,3-dihydro-1H-inden-4-yl]urea;5-(2-methoxy-4-pyridinyl)-2,3-dihydro-1H-inden-4-amine |
|---|---|
| PubChem CID | 159954762 |
| Molecular Formula | C45H58N12O7S2 |
| Molecular Weight | 943.17 g/mol |
| Exact Mass | 942.40 |
| IUPAC Name | 1-[2-(dimethylamino)ethyl]pyrazole-3-sulfonamide;1-[1-[2-(dimethylamino)ethyl]pyrazol-3-yl]sulfonyl-3-[5-(2-methoxy-4-pyridinyl)-2,3-dihydro-1H-inden-4-yl]urea;5-(2-methoxy-4-pyridinyl)-2,3-dihydro-1H-inden-4-amine |
| SMILES | CN(C)CCn1ccc(S(N)(=O)=O)n1.COc1cc(-c2ccc3c(c2N)CCC3)ccn1.COc1cc(-c2ccc3c(c2NC(=O)NS(=O)(=O)c2ccn(CCN(C)C)n2)CCC3)ccn1 |
| InChI | InChI=1S/C23H28N6O4S.C15H16N2O.C7H14N4O2S/c1-28(2)13-14-29-12-10-21(26-29)34(31,32)27-23(30)25-22-18-6-4-5-16(18)7-8-19(22)17-9-11-24-20(15-17)33-3;1-18-14-9-11(7-8-17-14)13-6-5-10-3-2-4-12(10)15(13)16;1-10(2)5-6-11-4-3-7(9-11)14(8,12)13/h7-12,15H,4-6,13-14H2,1-3H3,(H2,25,27,30);5-9H,2-4,16H2,1H3;3-4H,5-6H2,1-2H3,(H2,8,12,13) |
| InChIKey | OCOMWRNMZNPIMD-UHFFFAOYSA-N |
| XLogP | 4.43 |
| TPSA | 247.81 Ų |
| H-Bond Donors | 4 |
| H-Bond Acceptors | 16 |
| Rotatable Bonds | 14 |
| Heavy Atoms | 66 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 943.17 |
| LogP ≤ 5 | 4.43 |
| H-Bond Donors ≤ 5 | 4 |
| H-Bond Acceptors ≤ 10 | 16 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'aniline', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 159954762 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.